OnKure Therapeutics (OKUR) Institutional Ownership $2.39 -0.06 (-2.45%) Closing price 04:00 PM EasternExtended Trading$2.38 -0.01 (-0.42%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for OnKure Therapeutics (NASDAQ:OKUR)CurrentInstitutional OwnershipPercentage90.98%Number ofInstitutional Buyers(last 12 months)34TotalInstitutional Inflows(last 12 months)$70.62MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$110.34K Get OKUR Insider Trade Alerts Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data OKUR Institutional Buying and Selling by Quarter OnKure Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Shay Capital LLC782,046$1.87M0.2%+417.8%5.789% 8/15/2025 Rangeley Capital LLC29,902$71K0.1%N/A0.221% 8/15/2025 Acorn Capital Advisors LLC2,839,674$6.79M4.4%+97.2%21.019% 8/13/2025 Affinity Asset Advisors LLC347,990$832K0.1%-11.7%2.576% 8/12/2025 XTX Topco Ltd10,643$25K0.0%N/A0.079% 8/12/2025 Highbridge Capital Management LLC663,607$1.59M0.1%+51.2%4.912% 8/8/2025 Bailard Inc.14,239$34K0.0%N/A0.105% 5/16/2025ADAR1 Capital Management LLC10,000$43K0.0%N/A0.074% 5/14/2025Affinity Asset Advisors LLC394,159$1.70M0.2%+173.4%2.934% 2/17/2025Vestal Point Capital LP635,000$5.46M0.3%N/A19.012% Get the Latest News and Ratings for OKUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OnKure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Two Sigma Advisers LP14,228$122K0.0%N/A0.426% 2/17/2025Tang Capital Management LLC294,626$2.53M0.2%N/A8.821% 2/17/2025Shay Capital LLC15,016$129K0.0%N/A0.450% 2/17/2025Sphera Funds Management LTD.87,354$751K0.1%N/A2.615% 2/17/2025Prosight Management LP63,754$548K0.2%N/A1.909% 2/17/2025OMERS ADMINISTRATION Corp12,100$104K0.0%N/A0.362% 2/17/2025NEA Management Company LLC478,548$4.12M0.2%N/A14.328% 2/17/2025Millennium Management LLC144,099$1.24M0.0%N/A4.314% 2/17/2025Deep Track Capital LP523,989$4.51M0.2%N/A15.688% 2/17/2025Cubist Systematic Strategies LLC20,549$177K0.0%N/A0.615% 2/17/2025Cantor Fitzgerald L. P.35,700$294K0.0%N/A1.069% 2/17/2025Citadel Advisors LLC1,074,314$8.78M0.0%N/A32.165% 2/17/2025Bank of America Corp DE249,642$2.15M0.0%N/A7.474% 2/17/2025683 Capital Management LLC43,371$373K0.0%N/A1.299% 2/17/2025Acorn Capital Advisors LLC1,439,674$12.38M6.8%N/A43.104% 2/14/2025Samsara BioCapital LLC824,155$7.09M1.0%N/A24.675% 2/14/2025Nantahala Capital Management LLC54,777$471K0.0%N/A1.640% 2/14/2025Northern Trust Corp19,177$165K0.0%N/A0.574% 2/14/2025Boothbay Fund Management LLC78,021$671K0.0%N/A2.336% 2/14/2025Altium Capital Management LLC218,386$1.88M0.5%N/A6.539% 2/13/2025Affinity Asset Advisors LLC144,159$1.24M0.2%N/A4.316% 2/13/2025Carlyle Group Inc.269,895$2.33M0.5%N/A8.081% 2/13/2025Walleye Capital LLC13,495$116K0.0%N/A0.404% 2/13/2025XTX Topco Ltd18,633$160K0.0%N/A0.558% 2/13/2025Barclays PLC8,741$75K0.0%N/A0.262% 2/13/2025Renaissance Technologies LLC47,450$408K0.0%N/A1.421% 2/12/2025Aldebaran Capital LLC45,572$392K0.4%N/A1.363% 2/12/2025Aisling Capital Management LP88,607$762K0.3%N/A2.651% 2/12/2025Geode Capital Management LLC76,599$659K0.0%N/A2.291% 2/12/2025Highbridge Capital Management LLC399,743$3.44M0.1%N/A11.958% (Data available from 1/1/2016 forward) OKUR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OKUR shares? During the previous two years, 34 institutional investors and hedge funds held shares of OnKure Therapeutics. The most heavily invested institutionals were Citadel Advisors LLC ($8.78M), Samsara BioCapital LLC ($7.09M), Acorn Capital Advisors LLC ($6.79M), Vestal Point Capital LP ($5.46M), Deep Track Capital LP ($4.51M), NEA Management Company LLC ($4.12M), and Tang Capital Management LLC ($2.53M).Learn more on OnKure Therapeutics' institutional investors. What percentage of OnKure Therapeutics' stock is owned by institutional investors? 90.98% of OnKure Therapeutics' stock is owned by institutional investors. Learn more on OKUR's institutional investor holdings. Which institutional investors have been buying OnKure Therapeutics' stock? Of the 34 institutional investors that purchased OnKure Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acorn Capital Advisors LLC ($2.84M), Citadel Advisors LLC ($1.07M), Samsara BioCapital LLC ($824.16K), Shay Capital LLC ($646.02K), Vestal Point Capital LP ($635K), Highbridge Capital Management LLC ($624.55K), and Deep Track Capital LP ($523.99K). How much institutional buying is happening at OnKure Therapeutics? Institutional investors have bought a total of 10,009,976 shares in the last 24 months. This purchase volume represents approximately $70.62M in transactions. Which of OnKure Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold OnKure Therapeutics stock in the last 24 months: Affinity Asset Advisors LLC ($46.17K). How much institutional selling is happening at OnKure Therapeutics? Institutional investors have sold a total of 46,169 shares in the last 24 months. This volume of shares sold represents approximately $110.34K in transactions. Related Companies Cybin Major Shareholders Citius Oncology Major Shareholders Molecular Partners Major Shareholders Cardiff Oncology Major Shareholders Alpha Cognition Major Shareholders Zura Bio Major Shareholders Forte Biosciences Major Shareholders MEI Pharma Major Shareholders Invivyd Major Shareholders TuHURA Biosciences Major Shareholders This page (NASDAQ:OKUR) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.